Home › Activist investors › Kanen Wealth
Campaign activist. Positions and campaigns from Kanen Wealth’s SEC filings. Updated November 20, 2026.
No active campaign by this definition (see How to read this).
| Company | Stake | Source | First disclosed | Last change | Since previous filing | Flags | Stated intent |
|---|---|---|---|---|---|---|---|
| Barnes & Noble Education, Inc. | 9.54%3,308,081 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Sep 3, 2026 | Oct 16, 2024 | Decreased Nov 13, 2026 | ▼ 0.21 pts | Decreased | 13F: none stated |
| Inspired Entertainment, Inc. | 8.69%2,289,979 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 2, 2026 | Nov 14, 2022 | Decreased Nov 13, 2026 | ▼ 1.00 pts | Decreased | 13F: none stated |
| Fossil Group, Inc. | 5.11%3,022,258 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 5, 2026 | Feb 18, 2026 | Increased Nov 13, 2026 | ▲ 3.63 pts | Increased | 13F: none stated |
| Zevia PBC | 4.26%2,908,236 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 | May 18, 2026 | Increased Nov 13, 2026 | ▲ 0.32 pts | Increased | 13F: none stated |
| Entravision Communications Corporation | 3.86%3,547,800 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 | Aug 13, 2026 | Increased Nov 13, 2026 | ▲ 0.48 pts | Increased | 13F: none stated |
| Apyx Medical Corporation | 3.68%1,551,235 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 4, 2026 | Aug 13, 2026 | Increased Nov 13, 2026 | ▲ 3.50 pts | Increased | 13F: none stated |
| TheRealReal, Inc. | 1.52%1,899,304 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 22, 2026 | Sep 6, 2024 | Increased Nov 13, 2026 | ▲ 0.22 pts | Increased | 13F: none stated |
| ONE Group Hospitality, Inc. | 14.1%4,348,419 shares | Schedule 13D/A, filed Jul 10, 2025 | Jun 11, 2025 | Decreased Jul 10, 2025 | ▼ 1.10 pts | — | Standard Item 4 language |
| Outdoor Holding Company | 9.99%11,594,794 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 5, 2026 | Jun 13, 2025 | — | ▲ 0.08 pts | — | 13F: none stated |
| Allot Ltd. | 9.8%4,793,041 shares | Schedule 13D, filed Jun 25, 2026 | Jun 25, 2026 | — | — | — | Seeks changes or engagement |
| Data I/O Corporation | 8.07%839,421 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Jul 31, 2026 | Aug 24, 2021 | — | 0.00 pts | — | 13F: none stated |
| Xponential Fitness, Inc. | 4.56%1,702,669 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 | Feb 18, 2026 | — | 0.00 pts | — | 13F: none stated |
| Immersion Corporation | 3.05%1,013,700 shares | 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Sep 8, 2026 | Oct 16, 2024 | — | 0.00 pts | — | 13F: none stated |
Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.
Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.
“The Reporting Persons recently engaged with the Issuer's management and Board of Directors regarding opportunities for value creation. Following the Issuer's announcement on June 23, 2026 that it has authorized a share repurchase program of up to $40 million of the Shares, the Reporting Persons no longer hold securities of the Issuer…”
Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.
| Company | Outcome or last status | Date | First filing | Highest stage | Filings | Meeting / votes |
|---|---|---|---|---|---|---|
| Quipt Home Medical Corp. | Stake reported below 5% | May 28, 2025 | Jan 10, 2025 | — | latest (4) | — |
| Orion Energy Systems, Inc. | Settled (agreement with the company) | Mar 9, 2023 | Mar 9, 2023 | — | latest (1) | — |
| 1847 Goedeker Inc. | Settled (agreement with the company) | Oct 21, 2021 | Oct 21, 2021 | — | latest (1) | — |
| Meet Group, Inc. | Settled (agreement with the company) | Jan 9, 2018 | Jan 9, 2018 | — | latest (1) | — |
| Company | Last stake | Source | Outcome | Date |
|---|---|---|---|---|
| Arhaus, Inc. | 1.56% | 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Mar 31, 2026 | Not in the latest 13F | Nov 13, 2026 |
| SKYX Platforms Corp. | 1.36% | 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Jul 31, 2026 | Not in the latest 13F | Nov 13, 2026 |
| EGAIN Corp | 4.4% | Schedule 13D/A, filed Nov 13, 2025 | Reported below 5% in a 13D/A | Nov 13, 2025 |
| Quipt Home Medical Corp. | 4.4% | Schedule 13D/A, filed May 28, 2025 | Reported below 5% in a 13D/A | May 28, 2025 |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
No proxy contest has gone to a vote since July 1, 2023.
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| Quipt Home Medical Corp. | Settlement | agreement with the company | Mar 4, 2025 | Jan 10, 2025 |
| Orion Energy Systems, Inc. | Settlement | agreement with the company | Mar 9, 2023 | Mar 9, 2023 |
| 1847 Goedeker Inc. | Settlement | agreement with the company | Oct 21, 2021 | Oct 21, 2021 |
| Meet Group, Inc. | Settlement | agreement with the company | Jan 9, 2018 | Jan 9, 2018 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 4 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.
“During the Restricted Period (as defined below), Kanen has agreed to vote all of the common shares of the Company (the “Common Shares”) and any other securities of the Company entitled to vote that are beneficially owned by Kanen and/or over which Kanen has control or direction, in favor of each director nominated and recommended by the Company’s Board of Directors’ (the “Board”) for election and in accordance with recommendations by the Board on all other proposals or busi…” 8-K, Mar 4, 2025
“Effective on March 7, 2023, the Board of Directors (the “Board”) of Orion Energy Systems, Inc. (the “Company”) appointed Richard A. Shapiro to the Board.” 8-K, Mar 9, 2023
“…anen Group shall be provided the final list of five (5) candidates immediately following the execution of this Agreement, and (B) the Kanen Group shall select the New Directors and the Board and all applicable committees of the Board shall appoint the New Directors to the Board no later than two (2) business days after the execution of this Agreement, (ii) nominate the New Directors for election to the Board at the 2021 Annual Meeting and (iii) recommend, support and solicit…” 8-K, Oct 21, 2021
“If the Board does not appoint such Replacement Director selected by the Kanen Group to the Board consistent with the terms of this Agreement, the Kanen Group shall be permitted to continue to select substitute nominee(s) pursuant to the New Director Identification Process (provided that, for the avoidance of doubt, the Company shall update and supplement such list of five (5) candidates so that the Kanen Group has a reasonable amount of time to evaluate a full list of five (5…” 8-K, Oct 21, 2021
“(ii) vote, or cause to be voted, all shares of Common Stock beneficially owned by the Kanen Group in favor of each of the nominees for election as directors nominated by the Board and recommended by the Board (and not in favor of any other nominees to serve on the Board), and, except in connection with any Extraordinary Transaction or Other Voting Recommendation (as defined below), with respect to each of the proposals identified in the Company’s definitive proxy statement or…” 8-K, Oct 21, 2021
“(ii) concurrent with the appointment of the New Director to the Board, appoint the New Director to at least one (1) of the four (4) standing committees of the Board; provided that, with respect to such committee appointment, the New Director is and continues to remain eligible to serve as a member of such committee pursuant to applicable law and the rules of NASDAQ, if any, that are applicable to the composition of such committee;” 8-K, Jan 9, 2018
“If the Recommended Candidate selected by the Board is unable to serve as a director for any reason as of the Appointment Date or does not provide the Company with the New Director Consent at or prior to the Appointment Date, then the Company and the Investor Group shall work together in good faith to identify and select a replacement director candidate to be appointed to the Board which shall only be appointed to the Board after having been mutually agreed upon by both the Co…” 8-K, Jan 9, 2018
“(ii) vote, or cause to be voted, all shares of Common Stock beneficially owned by each Investor and their respective Affiliates and Associates on the Company’s proxy card or voting instruction form in favor of (a) each of the directors nominated by the Board and recommended by the Board in the election of directors (and not in favor of any other nominees to serve on the Board), and (b) except in connection with any Opposition Matter (as defined below) or Other Voting Recommen…” 8-K, Jan 9, 2018
Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Kanen Wealth’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.
| Holder | Form | Date | Stake |
|---|---|---|---|
| Gate City Capital Management, LLC | Schedule 13G | Feb 17, 2026 | 13.6% |
| American Century Investment Management, Inc. | Schedule 13G | May 1, 2026 | 11.1% |
| Alexandra Seros | Schedule 13G | May 21, 2026 | 10.0% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Wasatch Advisors LP | Schedule 13G | Mar 5, 2026 | 4.7% |
| Voya Financial, Inc. | Schedule 13G | May 5, 2026 | 5.1% |
| Vanguard Capital Management | Schedule 13G | Jul 31, 2026 | 5.0% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Bubble Holdings, LLC | Schedule 13D | Oct 29, 2026 | 16.1% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Voss Value Master Fund, LP | Schedule 13D | Mar 4, 2026 | 18.2% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| BlackRock, Inc. | Schedule 13G | Feb 5, 2025 | 4.9% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Forager Fund, L.P. | Schedule 13D | Dec 11, 2024 | 9.7% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Greenhaven Road Investment Management, L.P. | Schedule 13D | May 17, 2024 | 9.9% |
| Toro 18 Holdings LLC | Schedule 13D | Jun 12, 2024 | — |
| Bernard Selz | Schedule 13G | Jan 6, 2025 | 3.4% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Philotimo Fund, LP | Schedule 13D | Nov 1, 2024 | 6.8% |